Weill Cornell Imaging at NewYork-Presbyterian
416 East 55th Street
New York, NY 10022
New and Existing Patients
Already a patient?
Login or sign-upto Connect Patient Portal to make an appointment
Locations and Appointments
Insurances Accepted
Please contact the doctor's office to verify that your insurance is accepted.
AETNA
Aetna - NYP
Anthem Blue Cross/Blue Shield
Anthem Blue Cross/Blue Shield Healthplus
GHI
Health Insurance Plan of NY (HIP)
Oxford Health Plans
United Healthcare
VNSNY CHOICE
About Joanna Weeks, M.D.
Joanna K. Weeks, M.D., is a radiologist specializing in Interventional Radiology and Nuclear Medicine Imaging and Therapy. She is an Assistant Professor of Clinical Radiology at Weill Cornell Medicine in the Division of Interventional Radiology and an Assistant Attending Radiologist at the New York-Presbyterian Hospital-Weill Cornell.
Dr. Weeks joined the Weill Cornell faculty in 2024 after completing her residency and fellowships in Interventional Radiology and Nuclear Medicine Imaging and Therapy at the Hospital of the University of Pennsylvania in Philadelphia. She served as Chief Fellow in Nuclear Radiology from 2022 to 2023. In 2023, she was recognized for her commitment to de...
Education
- Degrees: College of William and Mary
- Degrees: Columbia University College of Physicians and Surgeons
Languages
- English
Titles & Positions
- Assistant Attending Radiologist
- Assistant Professor of Clinical Radiology
Education
- Degrees: Columbia University College of Physicians and Surgeons
- Degrees: College of William and Mary
Titles & Positions
- Assistant Attending Radiologist
- Assistant Professor of Clinical Radiology
Languages Spoken
- english
Research
[18F]Fluorthanatrace PET in Ovarian Cancer: Comparison with [18F]FDG PET, Lesion Location, Tumor Grade, and Breast Cancer Gene Mutation Status.
January 03, 202568 Ga-DOTATATE PET to Characterize Lesions in the Neuroaxis.
December 01, 2023[18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study.
April 14, 2023